Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats

Neurochemistry International

Volumn 56, Issue 1, 2010, Pages 152-160

  Cirillo, Giovanni ^a   Maggio, Nicola ^a,c   Bianco, Maria Rosaria ^a   Vollono, Cecilia ^a   Sellitti, Stefania ^a   Papa, Michele ^a,b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

3 Nitropropionic acid; Glial glutamate transporter GLAST; Reactive astrocytosis; Striatum

Indexed keywords

3 NITROPROPIONIC ACID; EXCITATORY AMINO ACID TRANSPORTER; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN C FOS; SUBSTANCE P;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BASAL GANGLION; CAUDATE NUCLEUS; CONTROLLED STUDY; DISEASE MODEL; GLIA CELL; HUNTINGTON CHOREA; MALE; MOLECULAR MECHANICS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; RISK FACTOR; UPREGULATION;

ANIMALS; ASTROCYTES; BASAL GANGLIA; BASAL GANGLIA DISEASES; BEHAVIOR, ANIMAL; DISABILITY EVALUATION; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID TRANSPORTER 1; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HUNTINGTON DISEASE; MALE; MOVEMENT DISORDERS; NEURONS; NEUROPSYCHOLOGICAL TESTS; NEUROTOXINS; NITRO COMPOUNDS; PROPIONIC ACIDS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; SUBSTANCE P; SYNAPTIC TRANSMISSION; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 73449117474     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.09.013     Document Type: Article

References (67)

1. Bal-Price A., and Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21 (2001) 6480-6491
2. Barbeito L.H., Pehar M., Cassina P., Vargas M.R., Peluffo H., Viera L., Estevez A.G., and Beckman J.S. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res. Rev. 47 (2004) 263-274
3. Bogdanov M.B., Ferrante R.J., Kuemmerle S., Klivenyi P., and Beal M.F. Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease. J. Neurochem. 71 (1998) 2642-2644
4. Borlongan C.V., Koutouzis T.K., and Sanberg P.R. 3-Nitropropionic acid animal model and Huntington's disease. Neurosci. Biobehav. Rev. 21 (1997) 289-293
5. Borlongan C.V., Nishino H., and Sanberg P.R. Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation. Neurosci. Res. 28 (1997) 185-189
6. Brouillet E., Conde F., Beal M.F., and Hantraye P. Replicating Huntington's disease phenotype in experimental animals. Prog. Neurobiol. 59 (1999) 427-468
7. Brouillet E., Hantraye P., Ferrante R.J., Dolan R., Leroy-Willig A., Kowall N.W., and Beal M.F. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7105-7109
8. Brouillet E., Jacquard C., Bizat N., and Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J. Neurochem. 95 (2005) 1521-1540
9. Browne S.E. Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models. Ann. N. Y. Acad. Sci. 1147 (2008) 358-382
10. Cattaneo E., Zuccato C., and Tartari M. Normal huntingtin function: an alternative approach to Huntington's disease. Nat. Rev. Neurosci. 6 (2005) 919-930
11. Cavaliere C., Cirillo G., Bianco M.R., Rossi F., De Novellis V., Maione S., and Papa M. Gliosis alters expression and uptake of spinal glial amino acid transporters in a mouse neuropathic pain model. Neuron Glia Biol. 3 (2007) 141-153
12. Chaudhry F.A., Lehre K.P., van Lookeren Campagne M., Ottersen O.P., Danbolt N.C., and Storm-Mathisen J. Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15 (1995) 711-720
13. 2+ signals in neuronal cells. Eur. J. Pharmacol. 447 (2002) 131-140
14. Chyi T., and Chang C. Temporal evolution of 3-nitropropionic acid-induced neurodegeneration in the rat brain by T2-weighted, diffusion-weighted, and perfusion magnetic resonance imaging. Neuroscience 92 (1999) 1035-1041
15. Cicchetti F., Gould P.V., and Parent A. Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's disease. Brain Res. 730 (1996) 232-237
16. Cicchetti F., Prensa L., Wu Y., and Parent A. Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease. Brain Res. Rev. 34 (2000) 80-101
17. Colangelo A.M., Bianco M.R., Vitagliano L., Cavaliere C., Cirillo G., De Gioia L., Diana D., Colombo D., Redaelli C., Zaccaro L., Morelli G., Papa M., Sarmientos P., Alberghina L., and Martegani E. A new nerve growth factor-mimetic peptide active on neuropathic pain in rats. J. Neurosci. 28 (2008) 2698-2709
18. Cole A.J., Saffen D.W., Baraban J.M., and Worley P.F. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 340 (1989) 474-476
19. Custer S.K., Garden G.A., Gill N., Rueb U., Libby R.T., Schultz C., Guyenet S.J., Deller T., Westrum L.E., Sopher B.L., and La Spada A.R. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat. Neurosci. 9 (2006) 1302-1311
20. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65 (2001) 1-105
21. Dervan A.G., Meshul C.K., Beales M., McBean G.J., Moore C., Totterdell S., Snyder A.K., and Meredith G.E. Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease. Exp. Neurol. 190 (2004) 145-156
22. 2+ exchanger. Exp. Neurol. 145 (1997) 38-45
23. Deshpande S.B., and Nishino H. In vitro protection of 3-nitropropionic acid-induced toxicity of astrocytes by basic fibroblast growth factor and thrombin. Brain Res. 783 (1998) 28-36
24. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol. Ther. 81 (1999) 163-221
25. Fernagut P.O., Diguet E., Stefanova N., Biran M., Wenning G.K., Canioni P., Bioulac B., and Tison F. Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation. Neuroscience 114 (2002) 1005-1017
26. 2+ overload induced by a mitochondrial toxin, 3-nitropropionic acid. Neuroscience 87 (1998) 497-507
27. Galas M.C., Bizat N., Cuvelier L., Bantubungi K., Brouillet E., Schiffmann S.N., and Blum D. Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms. Neurobiol. Dis. 15 (2004) 152-159
28. Garcia M., Vanhoutte P., Pages C., Besson M.J., Brouillet E., and Caboche J. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module. J. Neurosci. 22 (2002) 2174-2184
29. Ginsberg S.D., Martin L.J., and Rothstein J.D. Regional deafferentation down-regulates subtypes of glutamate transporter proteins. J. Neurochem. 65 (1995) 2800-2803
30. Giovannoni R., Maggio N., Bianco M.R., Cavaliere C., Cirillo G., Lavitrano M., and Papa M. Reactive astrocytosis and glial glutamate transporter clustering are early changes in a spinocerebellar ataxia type 1 transgenic mouse model. Neuron Glia Biol. 3 (2007) 335-351
31. Graham R.K., Pouladi M.A., Joshi P., Lu G., Deng Y., Wu N.P., Figueroa B.E., Metzler M., Andre V.M., Slow E.J., Raymond L., Friedlander R., Levine M.S., Leavitt B.R., and Hayden M.R. Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease. J. Neurosci. 29 (2009) 2193-2204
32. Guyot M.C., Hantraye P., Dolan R., Palfi S., Maziere M., and Brouillet E. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience 79 (1997) 45-56
33. Haydon P.G., and Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev. 86 (2006) 1009-1031
34. Hickey M.A., Kosmalska A., Enayati J., Cohen R., Zeitlin S., Levine M.S., and Chesselet M.F. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience 157 (2008) 280-295
35. Hughes E.G., Maguire J.L., McMinn M.T., Scholz R.E., and Sutherland M.L. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking. Brain Res. Mol. Brain Res. 124 (2004) 114-123
36. Landles C., and Bates G.P. Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep. 5 (2004) 958-963
37. Lehre K.P., Levy L.M., Ottersen O.P., Storm-Mathisen J., and Danbolt N.C. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J. Neurosci. 15 (1995) 1835-1853
38. Lehre K.P., and Danbolt N.C. The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J. Neurosci. 18 (1998) 8751-8757
39. Lobsiger C.S., and Cleveland D.W. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neurosci. 10 (2007) 1355-1360
40. Martin Aparicio E., and Lucas J.J. Molecular basis of Huntington's disease and possible pathogenic mechanisms. Rev. Neurol. 35 (2002) 212-220
41. McCracken E., Dewar D., and Hunter A.J. White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat. Brain Res. 892 (2001) 329-335
42. Morgan J.I., Cohen D.R., Hempstead J.L., and Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237 (1987) 192-197
43. Mrak R.E., and Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 26 (2005) 349-354
44. Musholt K., Cirillo G., Cavaliere C., Bianco M.R., Bock J., Helmeke C., Braun K., and Papa M. Neonatal separation stress reduces glial fibrillary acidic protein- and S100beta-immunoreactive astrocytes in the rat medial precentral cortex. Dev. Neurobiol. 69 (2009) 203-211
45. Olsen C., Rustad A., Fonnum F., Paulsen R.E., and Hassel B. 3-Nitropropionic acid: an astrocyte-sparing neurotoxin in vitro. Brain Res. 850 (1999) 144-149
46. Page K.J., Dunnett S.B., and Everitt B.J. 3-Nitropropionic acid-induced changes in the expression of metabolic and astrocyte mRNAs. Neuroreport 9 (1998) 2881-2886
47. Palfi S., Ferrante R.J., Brouillet E., Beal M.F., Dolan R., Guyot M.C., Peschanski M., and Hantraye P. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J. Neurosci. 16 (1996) 3019-3025
48. Papa M., Boscia F., Canitano A., Castaldo P., Sellitti S., Annunziato L., and Taglialatela M. Expression pattern of the ether-a-gogo-related (ERG) K+ channel-encoding genes ERG1, ERG2, and ERG3 in the adult rat central nervous system. J. Comp. Neurol. 466 (2003) 119-135
49. Paulsen J.S., Magnotta V.A., Mikos A.E., Paulson H.L., Penziner E., Andreasen N.C., and Nopoulos P.C. Brain structure in preclinical Huntington's disease. Biol. Psychiatry 59 (2006) 57-63
50. Paulson H.L., and Fischbeck K.H. Trinucleotide repeats in neurogenetic disorders. Annu. Rev. Neurosci. 19 (1996) 79-107
51. Reiner A., Perera M., Paullus R., and Medina L. Immunohistochemical localization of DARPP32 in striatal projection neurons and striatal interneurons in pigeons. J. Chem. Neuroanat. 16 (1998) 17-33
52. Rodriguez J.J., Olabarria M., Chvatal A., and Verkhratsky A. Astroglia in dementia and Alzheimer's disease. Cell Death Differ. 16 (2009) 378-385
53. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., Nash N., and Kuncl R.W. Localization of neuronal and glial glutamate transporters. Neuron 13 (1994) 713-725
54. Saffen D.W., Cole A.J., Worley P.F., Christy B.A., Ryder K., and Baraban J.M. Convulsant-induced increase in transcription factor messenger RNAs in rat brain. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 7795-7799
55. Saijo K., Winner B., Carson T.C., Collier J.G., Boyer L., Rosenfeld M.G., Gage F.H., and Glass C.K. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137 (2009) 47-59
56. Schmued L.C., and Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874 (2000) 123-130
57. Schmued L.C., and Hopkins K.J. Fluoro-Jade: novel fluorochromes for detecting toxicant-induced neuronal degeneration. Toxicol. Pathol. 28 (2000) 91-99
58. Schmued L.C., Stowers C.C., Scallet A.C., and Xu L. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res. 1035 (2005) 24-31
59. Seppi K., Mueller J., Bodner T., Brandauer E., Benke T., Weirich-Schwaiger H., Poewe W., and Wenning G.K. J. Neurol. 248 (2001) 866-869
60. Sheldon A.L., and Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 51 (2007) 333-355
61. Smith R., Brundin P., and Li J.Y. Synaptic dysfunction in Huntington's disease: a new perspective. Cell Mol. Life Sci. 62 (2005) 1901-1912
62. Sung B., Lim G., and Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J. Neurosci. 23 (2003) 2899-2910
63. Teunissen C.E., Steinbusch H.W., Angevaren M., Appels M., de Bruijn C., Prickaerts J., and de Vente J. Behavioural correlates of striatal glial fibrillary acidic protein in the 3-nitropropionic acid rat model: disturbed walking pattern and spatial orientation. Neuroscience 105 (2001) 153-167
64. Tilleux S., Goursaud S., and Hermans E. Selective up-regulation of GLT-1 in cultured astrocytes exposed to soluble mediators released by activated microglia. Neurochem. Int. 55 (2009) 35-40
65. Wullner U., Young A.B., Penney J.B., and Beal M.F. 3-Nitropropionic acid toxicity in the striatum. J. Neurochem. 63 (1994) 1772-1781
66. Xin W.J., Weng H.R., and Dougherty P.M. Plasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligation. Mol. Pain 26 (2009) 5-15
67. Zagami C.J., O'Shea R.D., Lau C.L., Cheema S.S., and Beart P.M. Regulation of glutamate transporters in astrocytes: evidence for a relationship between transporter expression and astrocytic phenotype. Neurotox. Res. 7 (2005) 143-149